Report Detail
Global Human Rho(D) Immune Globulin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4533665 |
- 08 June, 2023 |
- Global |
- 98 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Human Rho(D) Immune Globulin market size was valued at USD 36 million in 2022 and is forecast to a readjusted size of USD 57 million by 2029 with a CAGR of 6.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Rho(D) immune globulin (RhIG) is a medication used to prevent Rh isoimmunization in mothers who are Rh negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when Rh negative people are given Rh positive blood. It is given by injection into muscle or a vein. A single dose lasts 2 to 4 weeks.
This report is a detailed and comprehensive analysis for global Human Rho(D) Immune Globulin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Human Rho(D) Immune Globulin market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Rho(D) Immune Globulin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Rho(D) Immune Globulin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Rho(D) Immune Globulin market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Rho(D) Immune Globulin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Rho(D) Immune Globulin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include СЅL Веhrіng, Grіfоlѕ, Bayer, Kedrion Biopharma and Saol Therapeutics. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Human Rho(D) Immune Globulin market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Vial
Prefilled Syringe
Market segment by Application
Government Institution
Private Sector
Others
Major players covered
СЅL Веhrіng
Grіfоlѕ
Bayer
Kedrion Biopharma
Saol Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Rho(D) Immune Globulin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Rho(D) Immune Globulin, with price, sales, revenue and global market share of Human Rho(D) Immune Globulin from 2018 to 2023.
Chapter 3, the Human Rho(D) Immune Globulin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Rho(D) Immune Globulin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Rho(D) Immune Globulin market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Rho(D) Immune Globulin.
Chapter 14 and 15, to describe Human Rho(D) Immune Globulin sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Human Rho(D) Immune Globulin
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Human Rho(D) Immune Globulin Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Vial
- 1.3.3 Prefilled Syringe
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Human Rho(D) Immune Globulin Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Government Institution
- 1.4.3 Private Sector
- 1.4.4 Others
- 1.5 Global Human Rho(D) Immune Globulin Market Size & Forecast
- 1.5.1 Global Human Rho(D) Immune Globulin Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Human Rho(D) Immune Globulin Sales Quantity (2018-2029)
- 1.5.3 Global Human Rho(D) Immune Globulin Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 СЅL Веhrіng
- 2.1.1 СЅL Веhrіng Details
- 2.1.2 СЅL Веhrіng Major Business
- 2.1.3 СЅL Веhrіng Human Rho(D) Immune Globulin Product and Services
- 2.1.4 СЅL Веhrіng Human Rho(D) Immune Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 СЅL Веhrіng Recent Developments/Updates
- 2.2 Grіfоlѕ
- 2.2.1 Grіfоlѕ Details
- 2.2.2 Grіfоlѕ Major Business
- 2.2.3 Grіfоlѕ Human Rho(D) Immune Globulin Product and Services
- 2.2.4 Grіfоlѕ Human Rho(D) Immune Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Grіfоlѕ Recent Developments/Updates
- 2.3 Bayer
- 2.3.1 Bayer Details
- 2.3.2 Bayer Major Business
- 2.3.3 Bayer Human Rho(D) Immune Globulin Product and Services
- 2.3.4 Bayer Human Rho(D) Immune Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Bayer Recent Developments/Updates
- 2.4 Kedrion Biopharma
- 2.4.1 Kedrion Biopharma Details
- 2.4.2 Kedrion Biopharma Major Business
- 2.4.3 Kedrion Biopharma Human Rho(D) Immune Globulin Product and Services
- 2.4.4 Kedrion Biopharma Human Rho(D) Immune Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Kedrion Biopharma Recent Developments/Updates
- 2.5 Saol Therapeutics
- 2.5.1 Saol Therapeutics Details
- 2.5.2 Saol Therapeutics Major Business
- 2.5.3 Saol Therapeutics Human Rho(D) Immune Globulin Product and Services
- 2.5.4 Saol Therapeutics Human Rho(D) Immune Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Saol Therapeutics Recent Developments/Updates
3 Competitive Environment: Human Rho(D) Immune Globulin by Manufacturer
- 3.1 Global Human Rho(D) Immune Globulin Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Human Rho(D) Immune Globulin Revenue by Manufacturer (2018-2023)
- 3.3 Global Human Rho(D) Immune Globulin Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Human Rho(D) Immune Globulin by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Human Rho(D) Immune Globulin Manufacturer Market Share in 2022
- 3.4.2 Top 6 Human Rho(D) Immune Globulin Manufacturer Market Share in 2022
- 3.5 Human Rho(D) Immune Globulin Market: Overall Company Footprint Analysis
- 3.5.1 Human Rho(D) Immune Globulin Market: Region Footprint
- 3.5.2 Human Rho(D) Immune Globulin Market: Company Product Type Footprint
- 3.5.3 Human Rho(D) Immune Globulin Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Human Rho(D) Immune Globulin Market Size by Region
- 4.1.1 Global Human Rho(D) Immune Globulin Sales Quantity by Region (2018-2029)
- 4.1.2 Global Human Rho(D) Immune Globulin Consumption Value by Region (2018-2029)
- 4.1.3 Global Human Rho(D) Immune Globulin Average Price by Region (2018-2029)
- 4.2 North America Human Rho(D) Immune Globulin Consumption Value (2018-2029)
- 4.3 Europe Human Rho(D) Immune Globulin Consumption Value (2018-2029)
- 4.4 Asia-Pacific Human Rho(D) Immune Globulin Consumption Value (2018-2029)
- 4.5 South America Human Rho(D) Immune Globulin Consumption Value (2018-2029)
- 4.6 Middle East and Africa Human Rho(D) Immune Globulin Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Human Rho(D) Immune Globulin Sales Quantity by Type (2018-2029)
- 5.2 Global Human Rho(D) Immune Globulin Consumption Value by Type (2018-2029)
- 5.3 Global Human Rho(D) Immune Globulin Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Human Rho(D) Immune Globulin Sales Quantity by Application (2018-2029)
- 6.2 Global Human Rho(D) Immune Globulin Consumption Value by Application (2018-2029)
- 6.3 Global Human Rho(D) Immune Globulin Average Price by Application (2018-2029)
7 North America
- 7.1 North America Human Rho(D) Immune Globulin Sales Quantity by Type (2018-2029)
- 7.2 North America Human Rho(D) Immune Globulin Sales Quantity by Application (2018-2029)
- 7.3 North America Human Rho(D) Immune Globulin Market Size by Country
- 7.3.1 North America Human Rho(D) Immune Globulin Sales Quantity by Country (2018-2029)
- 7.3.2 North America Human Rho(D) Immune Globulin Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Human Rho(D) Immune Globulin Sales Quantity by Type (2018-2029)
- 8.2 Europe Human Rho(D) Immune Globulin Sales Quantity by Application (2018-2029)
- 8.3 Europe Human Rho(D) Immune Globulin Market Size by Country
- 8.3.1 Europe Human Rho(D) Immune Globulin Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Human Rho(D) Immune Globulin Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Human Rho(D) Immune Globulin Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Human Rho(D) Immune Globulin Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Human Rho(D) Immune Globulin Market Size by Region
- 9.3.1 Asia-Pacific Human Rho(D) Immune Globulin Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Human Rho(D) Immune Globulin Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Human Rho(D) Immune Globulin Sales Quantity by Type (2018-2029)
- 10.2 South America Human Rho(D) Immune Globulin Sales Quantity by Application (2018-2029)
- 10.3 South America Human Rho(D) Immune Globulin Market Size by Country
- 10.3.1 South America Human Rho(D) Immune Globulin Sales Quantity by Country (2018-2029)
- 10.3.2 South America Human Rho(D) Immune Globulin Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Human Rho(D) Immune Globulin Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Human Rho(D) Immune Globulin Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Human Rho(D) Immune Globulin Market Size by Country
- 11.3.1 Middle East & Africa Human Rho(D) Immune Globulin Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Human Rho(D) Immune Globulin Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Human Rho(D) Immune Globulin Market Drivers
- 12.2 Human Rho(D) Immune Globulin Market Restraints
- 12.3 Human Rho(D) Immune Globulin Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Human Rho(D) Immune Globulin and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Human Rho(D) Immune Globulin
- 13.3 Human Rho(D) Immune Globulin Production Process
- 13.4 Human Rho(D) Immune Globulin Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Human Rho(D) Immune Globulin Typical Distributors
- 14.3 Human Rho(D) Immune Globulin Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Human Rho(D) Immune Globulin. Industry analysis & Market Report on Human Rho(D) Immune Globulin is a syndicated market report, published as Global Human Rho(D) Immune Globulin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Human Rho(D) Immune Globulin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
